Total Voting Rights and Capital

Haleon PLC

02 April 2024

 

Haleon plc: Total Voting Rights and Capital

2 April 2024: As at 31 March 2024 the total number of shares issued by Haleon plc ("Haleon" or the "Company") with rights to vote is 9,132,301,104 ordinary shares of £0.01 each. There are no ordinary shares held in Treasury.

The figure of 9,132,301,104 may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Notifiable interests in Haleon may be sent to: [e-mail]

Amanda Mellor

Company Secretary

About Haleon

Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com. 

 

END